Analysis of interfraction prostate motion using megavoltage cone beam computed tomography
Analysis of interfraction prostate motion using megavoltage cone beam computed tomography
复制标题
DOI:
10.1016/j.ijrobp.2008.07.002
复制
发表时间:
2008-11-01
影响因子:
7
通讯作者:
Buatti, John M.
中科院分区:
文献类型:
--
作者:
Bylund, Kevin C.;Bayouth, John E.;Buatti, John M.
Purpose: Determine the degree of interfraction prostate motion and its components measured by using daily mega-voltage (MV) cone beam computed tomography (CBCT) imaging.Methods and Materials: A total of 984 daily MV CBCT images from 24 patients undergoing definitive intensity-modulated radiotherapy for localized prostate cancer were analyzed retrospectively. Pretreatment couch shifts, based on physician registration of MV CBCT to planning CT data sets, were used as a measure of daily interfraction motion. Off-line bony registration was performed to separate bony misalignment from internal organ motion. Interobserver and intraobserver variation studies were performed on 20 MV CBCT images.Results: Mean interfraction prostate motion was 6.7 mm, with the greatest single-axis deviation ill the anterior-posterior (AP) direction. The largest positional inaccuracy was accounted for by systematic deviations in bony misalignment, whereas random deviations occurred from bony misalignment and internal prostate motion. In the aggregate, All motion did not correlate with days elapsed since beginning therapy or on average with rectal size at treatment planning. Interobserver variation was greatest in the AP direction, decreased in experienced observers, and further decreased in intraobserver studies. Mean interfraction motion during the first 6 days of therapy, when used as a subsequent offset, reduced acceptable All planning target volume margins by 50%.Conclusion: The MV CBCT is a practical direct method of daily localization that shows significant interfraction motion with respect to conventional three-dimensional conformal and intensity-modulated radiotherapy margins, similar to that measured in other modalities. (C) 2008 Elsevier Inc.